Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|December 15, 2023
Structural insights into N-terminal methionine cleavage by the human mitochondrial methionine aminopeptidase, MetAP1DYeon Lee, Hayoung Kim, Eunji Lee, et al.
Biochemical Pharmacology|February 21, 2017
The N-terminal region of organic anion transporting polypeptide 1B3 (OATP1B3) plays an essential role in regulating its plasma membrane traffickingSe-Eun Chun, Nilay Thakkar, Yunseok Oh, et al.
International Journal of Biological Macromolecules|July 18, 2018
Structural basis for the substrate recognition of peptidoglycan pentapeptides by Enterococcus faecalis VanYBHyoun Sook Kim, Hyunggu Hahn, Jieun Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2026
Structural insights into SetA-mediated Rab1 glucosylation and PI3P-guided localization during early Legionella infectionHa Na Im, Yeon Lee, Yunju Song, et al.
Bioorganic Chemistry|March 29, 2016
Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeletonVu Thi Ha, Vu Tuan Kien, Le Huy Binh, et al.
Plos One|December 29, 2015
Structure and Stability of the Dimeric Triosephosphate Isomerase from the Thermophilic Archaeon Thermoplasma acidophilumSang Ho Park, Hyoun Sook Kim, Mi Seul Park, et al.
Clinical Epigenetics|May 21, 2020
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cellsManon Lernoux, Michael Schnekenburger, Hélène Losson, et al.
Pharmacological Research|July 4, 2020
The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemiaHélène Losson, Sruthi Reddy Gajulapalli, Manon Lernoux, et al.
Archives of Biochemistry and Biophysics|May 31, 2020
Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activitySujin Kim, Wonki Kim, Do-Hee Kim, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 3, 2015
Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as histone deacetylase inhibitors and antitumor agentsDo T M Dung, Phan T P Dung, Dao T K Oanh, et al.
Pageof 3